Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.

Centre de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigacions Sanitàries Pere Virgili, Universitat Rovira i Virgili, C, Sant Joan s/n, 43201 Reus, Spain.
BMC Gastroenterology (Impact Factor: 2.11). 02/2009; 9:3. DOI: 10.1186/1471-230X-9-3
Source: PubMed

ABSTRACT Paraoxonase-1 (PON1) is an antioxidant enzyme synthesized by the liver. It protects against liver impairment and attenuates the production of the pro-inflammatory monocyte chemoattractant protein-1 (MCP-1). We investigated the relationships between hepatic PON1 and MCP-1 expression in rats with liver disease and explored the possible molecular mechanisms involved.
CCl4 was administered for up to 12 weeks to induce liver damage. Serum and hepatic levels of PON1 and MCP-1, their gene and protein expression, nuclear transcription factors, and histological and biochemical markers of liver impairment were measured.
High levels of PON1 and MCP-1 expression were observed at 12th week in the hepatocytes surrounding the fibrous septa and inflammatory areas. CCl4-administered rats had an increased hepatic PON1 concentration that was related to decreased gene transcription and inhibited protein degradation. Decreased PON1 gene transcription was associated with PPARdelta expression. These changes were accompanied by increased hepatic MCP-1 concentration and gene expression. There were significant direct relationships between hepatic PON1 and MCP-1 concentrations (P = 0.005) and between PON1 and the amount of activated stellate cells (P = 0.001).
Our results from this experimental model suggest a hepato-protective role for PON1 against inflammation, fibrosis and liver disease mediated by MCP-1.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Krataksadaj: Cilj studije bio je da se ispita odnos izme -|u aktivnog (aciliranog) i neaktivnog (deaciliranog) grelina u serumu i drugih serumskih para metara kod crevnih para -zitskih infekcija i zdravih kontrola. Uobi~ajene mikro skop -ske metode (slani rastvor i rastvor joda, trihromatski otisak) kori{}ene su za identifikaciju crevnih parazita u uzorcima stolice 29 pacijenata Univer zitetske bolnice Firat. Serumski parametri odre|eni su u jednokratnom merenju seruma 29 pacijenata s parazitima i 18 zdravih kontrolnih subjekata. Nivoi aciliranog grelina i deaciliranog grelina u serumu izmereni su metodom radio imunoeseja. Paraoksonaza i arilesteraza su merene spektrofotometrijski na 405 nm i 270 nm. Koncen tracije aciliranog i deaciliranog gre lina u serumu bile su upadljivonìe kod pacijenata sa parazitima nego u kontrolnoj grupi. Nivoi glukoze, hole ste rola i triglicerida bili su vi{i kod crevnih parazitskih infekcija nego kod kontrola. [tavi{e, nije bilo korelacija izme|u nivoa grelina i indeksa telesne mase. Rezultati ukazuju na to da bi niski nivoi grelina i PON1/AE mogli bitivàni za pra}enje apetita kod crevnih parazitskih infekcija. Klju~ne re~i: serum, aktivni/neaktivni grelin, para okso -naza, arilesteraza, paraziti Summary: The aim of this work was to examine the re la -tion ship between active (acylated ghrelin) and inactive (de -sacylated ghrelin) ghrelin in the serum and other serum parameters in intestinal parasitic infections and healthy controls. Conventional microscopic methods (saline and iodine solutions, trichrome stain) were used to identify in -testinal parasites in stool samples of 29 subjects attending Firat University Hospital. Serum parameters were assessed in a single measurement of serum from 29 parasite sub jects, and in 18 healthy controls. Serum acylated ghrelin and desacylated ghrelin levels were measured using a com mer -cial radioimmunoassay (RIA) kit. Paraoxonase and ary l -esterase were measured by using a spectrophotometer at 405 nm and 270 nm, respectively. Serum concentrations of acylated ghrelin and desacylated ghrelin were mo re markedly decreased in helminth bearing patients than the control group. Glucose, cholesterol and triglyce ride levels were higher in intestinal parasitic infections than in controls. Furthermore, there were no correlations between ghrelin levels and BMI. These results indicate that low ghre lin and PON1/AE level may be important for appetite mo nitoring in intestinal parasitic infections.
    Journal of Medical Biochemistry 01/2010; 29(1). · 1.08 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative stress and inflammation underpin most diseases; their mechanisms are inextricably linked. Chronic inflammation is associated with oxidation, anti-inflammatory cascades are linked to decreased oxidation, increased oxidative stress triggers inflammation, and redox balance inhibits the inflammatory cellular response. Whether or not oxidative stress and inflammation represent the cause or consequence of cellular pathology, they contribute significantly to the pathogenesis of noncommunicable diseases (NCD). The incidence of obesity and other related metabolic disturbances are increasing, as are age-related diseases due to a progressively aging population. Relationships between oxidative stress, inflammatory signaling, and metabolism are, in the broad sense of energy transformation, being increasingly recognized as part of the problem in NCD. In this chapter, we summarize the pathologic consequences of an imbalance between circulating and cellular paraoxonases, the system for scavenging excessive reactive oxygen species and circulating chemokines. They act as inducers of migration and infiltration of immune cells in target tissues as well as in the pathogenesis of disease that perturbs normal metabolic function. This disruption involves pathways controlling lipid and glucose homeostasis as well as metabolically driven chronic inflammatory states that encompass several response pathways. Dysfunction in the endoplasmic reticulum and/or mitochondria represents an important feature of chronic disease linked to oxidation and inflammation seen as self-reinforcing in NCD. Therefore, correct management requires a thorough understanding of these relationships and precise interpretation of laboratory test results.
    Advances in clinical chemistry 01/2014; 63:247-308. · 4.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paraoxonase 1 (PON1) is an antioxidant enzyme which plays a central role in various diseases. However, the mechanism and function of PON1 protein in inflammation are poorly understood. Since PON1 protein alone cannot be delivered into cells, we generated a cell permeable PEP-1-PON1 protein using protein transduction domains, and examined whether it can protect against cell death in lipopolysaccharide (LPS) or hydrogen peroxide (H2O2)-treated Raw 264.7 cells as well as mice with 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced skin inflammation. We demonstrated that PEP-1-PON1 protein transduced into Raw 264.7 cells and markedly protected against LPS or H2O2-induced cell death by inhibiting cellular reactive oxygen species (ROS) levels, the inflammatory mediator's expression, activation of mitogen-activated protein kinases (MAPKs) and cellular apoptosis. Furthermore, topically applied PEP-1-PON1 protein ameliorates TPA-treated mice skin inflammation via a reduction of inflammatory response. Our results indicate that PEP-1-PON1 protein plays a key role in inflammation and oxidative stress in vitro and in vivo. Therefore, we suggest that PEP-1-PON1 protein may provide a potential protein therapy against oxidative stress and inflammation.
    PLoS ONE 01/2014; 9(1):e86034. · 3.53 Impact Factor

Full-text (2 Sources)

Available from
May 28, 2014